We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current PETS market cap is 87.76M. The company's latest EPS is USD 0.0110 and P/E is 376.36.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 65.39M | 58.87M | 62.41M | 78.24M | 71M |
| Operating Income | 2.96M | -769k | -7.11M | -2.13M | -441k |
| Net Income | 2.58M | -19k | -5.1M | -887k | -70k |
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 283.42M | 284.13M | 309.22M | 273.42M | 256.86M |
| Operating Income | 46.17M | 30.98M | 37.59M | 25.71M | -1.43M |
| Net Income | 37.74M | 25.85M | 30.6M | 21.1M | 233k |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 169.27M | 165.12M | 164.12M | 180.74M | 159.27M |
| Total Liabilities | 31.11M | 31.54M | 40.32M | 62.42M | 45.6M |
| Total Equity | 138.15M | 133.59M | 123.8M | 118.32M | 113.67M |
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 154.43M | 155.32M | 187.5M | 176.32M | 164.12M |
| Total Liabilities | 19.75M | 25.31M | 46.22M | 34.13M | 40.32M |
| Total Equity | 134.68M | 130.01M | 141.28M | 142.19M | 123.8M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 5.11M | 18.08M | 27.8M | 562k | -215k |
| Investing | -7.34M | -8.33M | -10.26M | -37.01M | -38M |
| Financing | -12.31M | -18.4M | -24.54M | -6.1M | -12.4M |
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 45.14M | 38.84M | 40.08M | 18.5M | 27.8M |
| Investing | -620k | -2.31M | -2.43M | -1.75M | -10.26M |
| Financing | -21.93M | -33.3M | -22.69M | -24.38M | -24.54M |
| Market Cap | 87.76M |
| Price to Earnings Ratio | 376.36 |
| Price to Sales Ratio | 0.34 |
| Price to Cash Ratio | 0.84 |
| Price to Book Ratio | 0.71 |
| Dividend Yield | 28.92% |
| Shares Outstanding | 21.15M |
| Average Volume (1 week) | 426.67k |
| Average Volume (1 Month) | 386.06k |
| 52 Week Change | -73.03% |
| 52 Week High | 16.18 |
| 52 Week Low | 4.01 |
| Spread (Intraday) | 0.3 (6.96%) |
| Company Name | PetMed Express Inc |
| Address |
420 south congress avenue delray beach, florida 33445 |
| Website | https://www.1800petmeds.com |
| Industry | drug & proprietary stores (5912) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
